New drugs for dyslipidemia:
-
Icosapent - Ethylester of eicosapentaenoic acid, Decreases VLDL-TG, As an adjunct to diet in severe hypertriglyceridemia
-
Lomitapide - Inhibits microsomal triglyceride transfer protein, decreases VLDL, chylomicrons synthesis
-
Alirocumab, Evolocumab - Proprotein convertase subtilisin kexin type 9 (PCSK-9) inhibitor. Blocks degradation of LDL-R, Decreases blood LDL
-
Bempedoic acid - Inhibits ATP citrate lyase. decreases synthesis of LDL.